Penny Stocks, Trade Alerts and Profits

Breaking News and Trade Alerts

Apptigo International, Inc. $APPG – Short Opportunity

I wanted to update our membership on our opinion of Apptigo International (OTCQB: APPG).  We now consider the shares of APPG to be an outstanding and rare shorting opportunity.  Starting about August 4, 2014 volume for APPG began to spike. At first it looked like people were “buying in” to APPG and pushing it upward. […]

Click this link to read the original post on StockGuru.com: Apptigo International, Inc. $APPG – Short Opportunity

Content from StockGuru.com is syndicated on over 1000 web sites and we welcome syndication as long as a valid link to StockGuru.com appears on the site. Copyright 2003 through 2013 with All rights protected unless a working link to StockGuru.com is enabled in the post. Contact us at: [email protected] – (469) 358-5200.

Categories:

Tags:

(Read more on StockGuru.com)

Content from StockGuru.com is syndicated on over 1000 web sites and we welcome syndication as long as a valid link to StockGuru.com appears on the site. Copyright 2003 through 2013 with All rights protected unless a working link to StockGuru.com is enabled in the post. Contact us at: [email protected] – (469) 358-5200.

StockGuru Latest Successes

Here are some of the latest successes on StockGuru:  Above is our coverage of First Columbia Gold Corp (FCGD). We alerted first to members via email, on the site, Facebook and Twitter on July 23, 2014. We further updated with an update on August 4, 2014 when it was already up 40%. It moved upContinue Reading

Vision Industries $VIIC is in The StockGuru Spotlight for Thursday #StockGuruSpotlight

Vision Industries (OTC: VIIC) is in The StockGuru Spotlight for Thursday, September 11, 2014. Huge volume on Wednesday with over 63 million shares traded.  Down 22% yesterday at the close despite being up as much as 44% intraday.  Recent spikes have put this stock up as much as 528% (Comparing close of August 27th withContinue Reading

Regen Biopharma $RGBP is in The StockGuru Spotlight for Thursday #StockGuruSpotlight #MedicalStock

Regen Biopharma $RGBP is in The StockGuru Spotlight for Thursday, September 11, 2014. Yesterday volume over ten times the average.  Although up part of the day, closed down sharply.  Important news update yesterday – shown below.  Here’s the key couple of lines – “The Company was informed that before it is cleared to initiate aContinue Reading

Sub-Penny: Mass Hysteria Entertainment Company $MHYS is in The StockGuru Spotlight for Thursday #StockGuruSpotlight #SubPenny

We offer sub-penny stocks very sparingly in The Spotlight. We are offering this one simply as it has a huge buzz. Lot’s of interest – and – potential for huge gains and losses. Play it right.  Mass Hysteria Entertainment Company (OTC: MHYS) is in The StockGuru Spotlight for Thursday, September 11, 2014.   Yesterday, whileContinue Reading

MRI Interventions $MRIC is in The StockGuru Spotlight for Thursday #StockGuruSpotlight

MRI Interventions (OTCQB: MRIC) is in The StockGuru Spotlight for Thursday, September 11, 2014. Already up 23% minutes after the open.  Volume is already three times the volume average.  New  CEO announced in press release today – see below.  Latest News:  MRI Interventions Announces Frank Grillo, Intuitive Surgical Executive, to Become CEO and Kimble JenkinsContinue Reading

Oak Ridge Energy Technologies $OKME is in The StockGuru Spotlight for Thursday #StockGuruSpotlight

Oak Ridge Energy Technologies (OTCQB: OKME) is in The StockGuru Spotlight for Thursday, September 11, 2014.  Already up 16.28% Light trader, so not one to move large trades into.    Latest from 10Q: (There’s much more than this, but this is a start.) Our Plan of Operation for 2014 consists of the following objectives: (1)Continue Reading

Boston Therapeutics $BTHE is in The StockGuru Spotlight for Thursday #StockGuruSpotlight

Boston Therapeutics (OTCQB: BTHE) is in The StockGuru Spotlight for Thursday, September 11, 2014.  Up 12.82% Strong early volume.  As above a dollar early in the year. Sliding since February, although the current price seems to be a solid resistance.  Excellent upside, with some risk.   Most Recent News: Boston Therapeutics Completes Enrollment of PatientsContinue Reading